Tactic Pharma LLC 4
4 · Monopar Therapeutics · Filed Dec 20, 2019
Insider Transaction Report
Form 4
Tactic Pharma LLC
10% Owner
Transactions
- Purchase
Common stock
2019-12-18$8.00/sh+125,000$1,000,000→ 291,667 total
Holdings
- 4,111,272.88(indirect: See Footnotes (1) and (2))
Common stock
Footnotes (2)
- [F1]This Form 4 is being filed on behalf of Tactic Pharma LLC, an Illinois limited liability company ("Tactic"), and its managers, Andrew P. Mazar, Chandler D. Robinson, Michael J. Brown, and Thomas V. O'Halloran (collectively, the "Reporting Persons"). The managers collectively have voting control over the securities described herein. The managers each disclaim ownership of the shares of common stock owned by Tactic, except to the extent of their pecuniary interest therein.
- [F2]Tactic has voting and investment power over 4,111,272.88 of the shares of common stock held by TacticGem LLC.